GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Barak Investment House Ltd (XTAE:BARI) » Definitions » EV-to-Revenue

Barak Investment House (XTAE:BARI) EV-to-Revenue : 3.07 (As of May. 13, 2024)


View and export this data going back to 2007. Start your Free Trial

What is Barak Investment House EV-to-Revenue?

EV-to-Revenue is calculated as enterprise value divided by its revenue. As of today, Barak Investment House's enterprise value is ₪49.82 Mil. Barak Investment House's Revenue for the trailing twelve months (TTM) ended in Dec. 2023 was ₪16.22 Mil. Therefore, Barak Investment House's EV-to-Revenue for today is 3.07.

The historical rank and industry rank for Barak Investment House's EV-to-Revenue or its related term are showing as below:

XTAE:BARI' s EV-to-Revenue Range Over the Past 10 Years
Min: 0.96   Med: 2.9   Max: 36.73
Current: 3.08

During the past 8 years, the highest EV-to-Revenue of Barak Investment House was 36.73. The lowest was 0.96. And the median was 2.90.

XTAE:BARI's EV-to-Revenue is ranked worse than
60.45% of 1024 companies
in the Drug Manufacturers industry
Industry Median: 2.38 vs XTAE:BARI: 3.08

The reason Enterprise Value is used is because Enterprise Value is more real in reflecting how much an investor pays when buying a company. For detais, go to Enterprise Value.

EV-to-Revenue is a similar ratio to PS Ratio, except here Enterprise Value instead of Market Cap is used in the calculation.

As of today (2024-05-13), Barak Investment House's stock price is ₪91.62. Barak Investment House's Revenue per Share for the trailing twelve months (TTM) ended in Dec. 2023 was ₪108.43. Therefore, Barak Investment House's PS Ratio for today is 0.84.


Barak Investment House EV-to-Revenue Historical Data

The historical data trend for Barak Investment House's EV-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Barak Investment House EV-to-Revenue Chart

Barak Investment House Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
EV-to-Revenue
Get a 7-Day Free Trial 15.10 5.17 1.99 1.63 3.00

Barak Investment House Quarterly Data
Jun18 Dec18 Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Jun23 Dec23
EV-to-Revenue Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 1.15 1.42 1.63 2.93 3.00

Competitive Comparison of Barak Investment House's EV-to-Revenue

For the Drug Manufacturers - Specialty & Generic subindustry, Barak Investment House's EV-to-Revenue, along with its competitors' market caps and EV-to-Revenue data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Barak Investment House's EV-to-Revenue Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Barak Investment House's EV-to-Revenue distribution charts can be found below:

* The bar in red indicates where Barak Investment House's EV-to-Revenue falls into.



Barak Investment House EV-to-Revenue Calculation

EV-to-Revenue is a similar ratio to PS Ratio, except here Enterprise Value instead of Market Cap is used in the calculation.

Barak Investment House's EV-to-Revenue for today is calculated as:

EV-to-Revenue=Enterprise Value (Today)/Revenue (TTM)
=49.822/16.217
=3.07

Barak Investment House's current Enterprise Value is ₪49.82 Mil.
Barak Investment House's Revenue for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was ₪16.22 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Barak Investment House  (XTAE:BARI) EV-to-Revenue Explanation

The reason Enterprise Value is used is because Enterprise Value is more real in reflecting how much an investor pays when buying a company. For detais, go to Enterprise Value.

Barak Investment House's PS Ratiofor today is calculated as:

PS Ratio=Share Price (Today)/Revenue per Share (TTM)
=91.62/108.432
=0.84

Barak Investment House's share price for today is ₪91.62.
Barak Investment House's Revenue per Share for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was ₪108.43.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Barak Investment House EV-to-Revenue Related Terms

Thank you for viewing the detailed overview of Barak Investment House's EV-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.


Barak Investment House (XTAE:BARI) Business Description

Traded in Other Exchanges
N/A
Address
Jabotinsky Street 7, Ramat Gan, ISR, 52520
Panaxia Labs Israel Ltd is engaged in the manufacture and distribution of medical cannabis products. The firm offers a wide range of products comprising oral tablets, sublingual tablets, medical oils, concentrations, pastilles, suppositories, topical creams, pain relief creams, and pain relief patches.

Barak Investment House (XTAE:BARI) Headlines

No Headlines